MetLife Inc. (NYSE:MET) went up by 2.73% from its latest closing price compared to the recent 1-year high of $73.18. The company’s stock price has collected 2.44% of gains in the last five trading sessions. The Wall Street Journal reported on 05/04/22 that Allstate Profit Weakens as Accidents, Claim Costs Increase
Is It Worth Investing in MetLife Inc. (NYSE :MET) Right Now?
MetLife Inc. (NYSE:MET) scored a price-to-earnings ratio above its average ratio, recording 8.11 x from its present earnings ratio. Plus, the 36-month beta value for MET is at 1.11. Opinions of the stock are interesting as 13 analysts out of 17 who provided ratings for MetLife Inc. declared the stock was a “buy,” while 2 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $77.50, which is $14.47 above the current price. MET currently public float of 685.11M and currently shorts hold a 1.52% ratio of that float. Today, the average trading volume of MET was 4.44M shares.
MET’s Market Performance
MET stocks went up by 2.44% for the week, with a monthly jump of 0.22% and a quarterly performance of -9.07%, while its annual performance rate touched 4.78%. The volatility ratio for the week stands at 2.48% while the volatility levels for the past 30 days are set at 2.45% for MetLife Inc. The simple moving average for the period of the last 20 days is -3.43% for MET stocks with a simple moving average of -4.06% for the last 200 days.
Analysts’ Opinion of MET
Many brokerage firms have already submitted their reports for MET stocks, with Citigroup repeating the rating for MET by listing it as a “Buy.” The predicted price for MET in the upcoming period, according to Citigroup is $77 based on the research report published on May 24th of the current year 2022.
Jefferies, on the other hand, stated in their research note that they expect to see MET reach a price target of $74. The rating they have provided for MET stocks is “Buy” according to the report published on January 26th, 2022.
Wolfe Research gave a rating of “Peer Perform” to MET, setting the target price at $70 in the report published on January 21st of the current year.
MET Trading at -5.86% from the 50-Day Moving Average
After a stumble in the market that brought MET to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -14.55% of loss for the given period.
Volatility was left at 2.45%, however, over the last 30 days, the volatility rate increased by 2.48%, as shares surge +0.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.09% lower at present.
During the last 5 trading sessions, MET rose by +2.44%, which changed the moving average for the period of 200-days by +1.41% in comparison to the 20-day moving average, which settled at $64.78. In addition, MetLife Inc. saw 0.06% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at MET starting from Goulart Steven J, who sale 56,857 shares at the price of $70.29 back on Feb 08. After this action, Goulart Steven J now owns 215,376 shares of MetLife Inc., valued at $3,996,376 using the latest closing price.
Khalaf Michel, the President & CEO of MetLife Inc., sale 42,748 shares at $60.74 during a trade that took place back on Dec 21, which means that Khalaf Michel is holding 144,015 shares at $2,596,535 based on the most recent closing price.
Stock Fundamentals for MET
Current profitability levels for the company are sitting at:
- +10.97 for the present operating margin
The net margin for MetLife Inc. stands at +9.41. Equity return is now at value 10.30, with 0.90 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.72.